[Form 4] PepGen Inc. Insider Trading Activity
Rhea-AI Filing Summary
PepGen Inc. reported a change to its President and CEO’s stock option grants. On November 4, 2025, the board approved a repricing of the executive’s outstanding stock options granted under the company’s 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, while all other terms of the options remain the same, except that the lower exercise price applies only if the executive satisfies a required retention period; otherwise, the original higher exercise prices will continue to apply.
The affected options, which are rights to buy PepGen common stock, generally vest over four years. For these grants, 25% of the shares vest on the first anniversary of the applicable vesting commencement or grant date, with the remaining shares vesting in 36 equal monthly installments, subject to continued service or employment on each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (Right to Buy) | 352,705 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 352,705 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 40,815 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 466,095 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 466,095 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 275,000 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 275,000 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 300,000 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 300,000 | $0.00 | -- |
Footnotes (1)
- On November 4, 2025, the Issuer's Board of Directors approved a repricing of the Reporting Person's outstanding stock options granted under the Issuer's 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan. The exercise price of eligible options was reduced to $4.53, with all other terms unchanged except that the reduced exercise price is available only if the Reporting Person satisfies the applicable retention period; otherwise, the original exercise price will apply. The transactions reported herein are exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934. This stock option vests over four years following the vesting commencement date (September 6, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. This stock option vests over four years following the vesting commencement date (September 17, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. This stock option vests over four years following the vesting commencement date (October 6, 2021) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. This stock option vests over four years following the vesting commencement date (March 7, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.
FAQ
What insider transaction did PepGen Inc. (PEPG) report in this Form 4?
The filing reports that PepGen’s President and CEO, who is also a director, had multiple existing stock option grants repriced by the board on November 4, 2025, with eligible options’ exercise prices reduced to $4.53 per share.
Which PepGen (PEPG) stock option plans were affected by the repricing?
The repricing applies to the reporting person’s outstanding options granted under PepGen’s 2020 Stock Plan, 2022 Stock Option and Incentive Plan, and 2024 Inducement Plan, as approved by the company’s board of directors.
What is the new exercise price of the PepGen CEO’s repriced stock options?
The exercise price of the reporting person’s eligible outstanding stock options was reduced to $4.53 per share, with all other option terms remaining unchanged except for the added retention condition.
Is the lower $4.53 exercise price for PepGen (PEPG) options subject to conditions?
Yes. The reduced $4.53 exercise price is available only if the reporting person satisfies the applicable retention period; if that condition is not met, the original higher exercise prices will apply.
How do the repriced PepGen stock options vest for the reporting person?
For the referenced grants, PepGen’s options generally vest over four years: 25% of the shares vest on the first anniversary of the vesting commencement or grant date, and the remaining shares vest in 36 equal monthly installments, subject to continued service or employment.
Are the PepGen CEO’s repriced stock options exempt under SEC rules?
The transactions are stated to be exempt pursuant to Rules 16b-6(d) and 16b-3 under the Securities Exchange Act of 1934.